Speaker Biography

Dr B.K.Madhusudhan

Head - Neurologist & Epileptologist, India

Title: Women With Epilepsy Will,Wise,Encourage #Change the Lives

Dr B.K.Madhusudhan

Dr Madhusudhan B.K. completed his MBBS from AIMS in 2002 and pursed his MD in General Medicine and DM Neurology from M.S Ramaiah Medical College and Hospitals. Later, he underwent training in epilepsy and epilepsy surgery workup with video EEG and intracranial electrode EEG monitoring at Toronto Western Hospital, UHN, Canada.He holds a good experience in treating patients with epilepsy, pre-surgical evaluation of medically refractory epilepsy, Vagus Nerve Stimulation (VNS), stroke, Parkinson disease, spondylosis, neuropathy and neuromuscular disorders, Acute neurological conditions such as ADEM, meningitis, GBS, headache , migraine etc.


Epilepsy refers to a disorder of brain function characterized by the periodic and unpredictable occurrence of seizure. It is 2nd most common neurological disorder after stroke and Common neurological disorder affecting 0.5-1.0 % population in India. Rochester epilepsy study also found that the prevalence of epilepsy was slightly higher in males than females (6.5 vs 6.0 per 1000 persons). Although most epilepsy syndromes are equally or more commonly found in males than in females, childhood absence epilepsy and the syndrome of photosensitive epilepsy are more common in females. In addition, some genetic disorders with associated epilepsy (eg, Rett syndrome and Aicardi syndrome) and eclamptic seizures in pregnancy can only occur in females. Few factors around epilepsy and its treatment are specific to women and do not apply in the same way to men. These include links between epilepsy and hormones, puberty, contraception, pregnancy and the menopause.

The efficacy of hormonal contraception diminishes in women who are taking CYP-450 enzyme inducing AEDs. Antiepileptic drugs (AEDs) reduce the efficacy of contraception methods and increase the risk of fetal malformations. Women with epilepsy have a higher risk of reproductive dysfunction, including polycystic ovarian syndrome, multiple ovarian cysts, anovulatory cycles and infertility. Women with epilepsy who are on AEDs and pregnant have an increased risk of fetal malformations. Prenatal exposure to AEDs is known to increase this risk to 4-9%. However, the vast majority of women with epilepsy deliver healthy babies. Breastfeeding in women taking AEDs is safe, providing that there is close monitoring of the baby for potential side effects.

Thus, Management of women with epilepsy is challenging. The treating clinician should be thoughtful about the correct choice of antiepileptic medications as it may create problems in reproductive planning and metabolic health. Thus, regular assessments need to be made from menarche onward.